Jia Hao Qiu
Corporate Officer/Principal presso Bioveda China Fund Ltd.
Profilo
Jia Hao Qiu is currently working as a Principal at Bioveda China Fund Ltd.
He previously held positions as an Independent Director at Jaguar Animal Health, Inc. and Jaguar Health, Inc., as well as a Member-Supervisory Board at CARsgen Therapeutics Co. Ltd.
Mr. Qiu completed his undergraduate degree at Shanghai Jiao Tong University.
Posizioni attive di Jia Hao Qiu
| Società | Posizione | Inizio |
|---|---|---|
| Bioveda China Fund Ltd. | Corporate Officer/Principal | 01/01/2010 |
Precedenti posizioni note di Jia Hao Qiu
| Società | Posizione | Fine |
|---|---|---|
CARsgen Therapeutics Co. Ltd.
 CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Direttore/Membro del Consiglio | - |
| JAGUAR HEALTH, INC. | Direttore/Membro del Consiglio | - |
Jaguar Animal Health, Inc.
 Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | - |
Formazione di Jia Hao Qiu
| Shanghai Jiao Tong University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| JAGUAR HEALTH, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Jaguar Animal Health, Inc.
Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
CARsgen Therapeutics Co. Ltd.
CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Health Technology |
| Bioveda China Fund Ltd. |
- Borsa valori
- Insiders
- Jia Hao Qiu
